Showing 321 - 340 results of 622 for search '"atherosclerosis"', query time: 0.04s Refine Results
  1. 321

    Association between atherogenic index of plasma and type 2 diabetic complications: a cross-sectional study by Yue-Yang Zhang, Yue-Yang Zhang, Yue-Yang Zhang, Yue-Yang Zhang, Yue-Yang Zhang, Xiao-Yu Yang, Xiao-Yu Yang, Xiao-Yu Yang, Xiao-Yu Yang, Xiao-Yu Yang, Qin Wan, Qin Wan, Qin Wan, Qin Wan, Qin Wan

    Published 2025-02-01
    “…BackgroundThe Atherogenic Index of Plasma (AIP) was originally developed primarily as a marker for assessing atherosclerosis. Consequently, this study investigates the potential association between AIP and type 2 diabetic complications through a cross-sectional design.MethodsThe National Metabolic Management Center(MMC) serves as a comprehensive platform dedicated to the establishment of standardized protocols for the diagnosis, treatment, and long-term follow-up of metabolic diseases. …”
    Get full text
    Article
  2. 322

    Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study by Vibeke Bratseth, Hanna D. Margeirsdottir, Gemma Chiva-Blanch, Martin Heier, Svein Solheim, Harald Arnesen, Knut Dahl-Jørgensen, Ingebjørg Seljeflot

    Published 2020-01-01
    “…Type 1 diabetes is a chronic disease including hyperglycemia and accelerated atherosclerosis, with high risk of micro- and macrovascular complications. …”
    Get full text
    Article
  3. 323
  4. 324

    Determinants of Vessel Targeting in Vasculitis by Gary S. Hoffman

    Published 2004-01-01
    “…This paper will explore the hypothesis that important differences exist in regions of the aorta that determine vulnerability to diseases, such as atherosclerosis, aortitis, giant cell arteritis and Takayasu's disease. …”
    Get full text
    Article
  5. 325

    The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis by Samuel García, Carmen Conde

    Published 2015-01-01
    “…In addition to the role of PARP-1 in DNA repair, multiple studies have also demonstrated its involvement in several inflammatory diseases, such as septic shock, asthma, atherosclerosis, and stroke, as well as in cancer. In these diseases, the pharmacological inhibition of PARP-1 has shown a beneficial effect, suggesting that PARP-1 regulates their inflammatory processes. …”
    Get full text
    Article
  6. 326

    Type A Behaviours and Heart Disease: Epidemiological and Experimental Foundations by Paul Bennett, Douglas Carroll

    Published 1990-01-01
    “…This paper critically examines three strands of evidence that concern the relationship between type A behaviours and coronary heart disease; prospective epidemiological studies of healthy populations, studies of those at high risk for coronary heart disease, and angiographic studies of atherosclerosis. The first of these would seem to provide the strongest test. …”
    Get full text
    Article
  7. 327

    Epidemiology and Etiology of Young Stroke by Dayna Griffiths, Jonathan Sturm

    Published 2011-01-01
    “…It remains the case, however, that atherosclerosis contributes to a large proportion of stroke in young patients, thus, conventional risk factors must be targeted aggressively.…”
    Get full text
    Article
  8. 328

    Lipophagy: Connecting Autophagy and Lipid Metabolism by Rajat Singh, Ana Maria Cuervo

    Published 2012-01-01
    “…Defective lipophagy has been already linked to important metabolic disorders such as fatty liver, obesity and atherosclerosis, and the age-dependent decrease in autophagy could underline the basis for the metabolic syndrome of aging.…”
    Get full text
    Article
  9. 329

    The Impact of Incretin-Based Medications on Lipid Metabolism by Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar

    Published 2021-01-01
    “…Thus, diabetes is commonly accompanied by varying degrees of dyslipidemia which is itself a major risk factor for further macro- and microvascular diabetes complications such as atherosclerosis and nephropathy. Therefore, normalizing lipid metabolism is an attractive goal for therapy in patients with diabetes. …”
    Get full text
    Article
  10. 330

    Proinflammatory Effects of C-Peptide in Different Tissues by Dusica Vasic, Daniel Walcher

    Published 2012-01-01
    “…Atherosclerosis is well known as an inflammatory disease that can lead to clinical complications such as heart attack or stroke. …”
    Get full text
    Article
  11. 331

    Osteoprotegerin in Cardiometabolic Disorders by C. Pérez de Ciriza, A. Lawrie, N. Varo

    Published 2015-01-01
    “…The association of OPG with diabetic complications (neuropathy, nephropathy, or retinopathy) as well as with atherosclerosis, coronary artery calcification, morbidity, and mortality is pointed out. …”
    Get full text
    Article
  12. 332

    Where Are We Heading with Noninvasive Clinical Vascular Physiology? Why and How Should We Assess Endothelial Function? by Elizabeth A. Ellins, Julian P. J. Halcox

    Published 2011-01-01
    “…The first investigations in humans involved invasive pharmacological vascular function testing, which have been used to gain a detailed understanding of the mechanisms involved in the pathogenesis of endothelial dysfunction and atherosclerosis as well as novel targets for intervention. …”
    Get full text
    Article
  13. 333

    Advanced Asymptomatic Carotid Disease and Cognitive Impairment: An Understated Link? by Irena Martinić-Popović, Arijana Lovrenčić-Huzjan, Vida Demarin

    Published 2012-01-01
    “…Neurosonological methods enable simple and noninvasive assessment of carotid stenosis in patients at risk of advanced atherosclerosis. Cognitive status in patients diagnosed with advanced carotid stenosis is routinely not taken into consideration, although if cognitive impairment is present, such patients should probably be called symptomatic. …”
    Get full text
    Article
  14. 334

    A Whole-Food Plant-Based Diet Reversed Angina without Medications or Procedures by Daniele Massera, Tarique Zaman, Grace E. Farren, Robert J. Ostfeld

    Published 2015-01-01
    “…Adoption of this form of lifestyle therapy should be among the first recommendations for patients with atherosclerosis.…”
    Get full text
    Article
  15. 335

    Dilating Vascular Diseases: Pathophysiology and Clinical Aspects by Ertan Yetkin, Selcuk Ozturk

    Published 2018-01-01
    “…Mostly, they have been defined as variants of atherosclerosis. Although there are some similarities in terms of pathogenesis, they are distinct from atherosclerotic disease of the vessels. …”
    Get full text
    Article
  16. 336

    Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus? by Joshua Juwono, Ryan D. Martinus

    Published 2016-01-01
    “…We will also look at the role of Hsp60 during immune cell activation in atherosclerosis, a significant risk factor during the pathogenesis of diabetes mellitus.…”
    Get full text
    Article
  17. 337

    Experience of instantaneous transaction coronary bypass surgery with carotid endarterectomy by B.M. Todurov, G.I. Kovtun, A.I. Matvijchuk, О.М. Postupalsky, А.О. Shpachuk, S.O. Sheludko, O.V. Revenko, O.A. Loskutov, M.A. Taranov

    Published 2017-09-01
    “…Based on experience (89 cases with zero lethality and no central nervous system complications), it is recommended to use this treatment approach in patients with atherosclerosis of coronary and brachiocephalic arteries. …”
    Get full text
    Article
  18. 338

    Cardiovascular and Renal Links along the Cardiorenal Continuum by José A. García-Donaire, Luis M. Ruilope

    Published 2011-01-01
    “…The majority of vascular events are caused by accelerated atherosclerosis. Moreover, cardiovascular events rarely occur in patients without underlying disease; rather, they typically take place as the final stage of a pathophysiological process that results in progressive vascular damage, including vital organ damage, specifically the kidney and the heart if these factors are uncontrolled. …”
    Get full text
    Article
  19. 339

    Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk by Marclébio Dourado, Frederico Cavalcanti, Lucio Vilar, Amaury Cantilino

    Published 2020-01-01
    “…It has high cardiovascular morbidity and mortality, with traditional risk factors such as atherosclerosis, hypertension, diabetes, smoking, and left ventricular hypertrophy being common. …”
    Get full text
    Article
  20. 340

    β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques by Taisuke Okano, Kengo Sato, Remina Shirai, Tomomi Seki, Koichiro Shibata, Tomoyuki Yamashita, Ayaka Koide, Hitomi Tezuka, Yusaku Mori, Tsutomu Hirano, Takuya Watanabe

    Published 2020-01-01
    “…Thus, μ-opioid receptor antagonists may be useful for the prevention and treatment of atherosclerosis.…”
    Get full text
    Article